BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland

Documenti analoghi

• A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
  di: Mononen, N, et al.
  Pubblicazione: (2001)
• CHEK2 variants associate with hereditary prostate cancer
  di: Seppälä, E H, et al.
  Pubblicazione: (2003)
• Germline Alterations of the RNASEL Gene, a Candidate HPC1 Gene at 1q25, in Patients and Families with Prostate Cancer
  di: Rökman, Annika, et al.
  Pubblicazione: (2002)
• No fumarate hydratase (FH) mutations in hereditary prostate cancer
  di: Lehtonen, R, et al.
  Pubblicazione: (2003)
• Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance
  di: Pakkanen, Sanna, et al.
  Pubblicazione: (2007)